Aug 14, 2020
Direct to Consumer DNA Test Kits Industry Report 2020-2025 Featuring Ancestry.com, 23andMe, MyHeritage, and Gene by Gene Among Others
Aug 11, 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
May 28, 2020
global market for viral vector and plasmid manufacturing is predicted to grow at a CAGR of 16.28% over the forecast period of 2020-2030
May 26, 2020
23andMe is Looking for Individuals Who've Recovered From COVID-19 Hospitalizations to Participate in New Study
May 26, 2020
Beacon Targeted Therapies Launches Its Latest Clinical Trial and Drug Database Solution - Beacon Gene Therapy
May 07, 2020
Lithuania Joins the European Biobanking Research Infrastructure as Observer
Apr 28, 2020
Denovo Biopharma To Acquire Tocagen's Entire Replicating Gene Therapy Platform and Related Assets
Apr 06, 2020
World's Leading Biobanks Join BC Platforms Global Data Partner Network to Advance Personalized Healthcare Research
Mar 25, 2020
Indiana Court of Appeals Affirms Murder Conviction, Use of DNA Evidence Produced by STRmix
Mar 25, 2020
Global Viral Vector and Plasmid DNA Manufacturing Market to Surpass US$ 2,205.6 Million by 2027 - CMI
Mar 19, 2020
Sequencing.com Launches Free Genetic Analysis To Assess Risk And Severity Of Coronavirus Infection For Each Individual
Mar 10, 2020
Global Transfection Technologies Market Analysis, 2020-2025 - Increasing R&D in the Field of Cell-Based Therapies
Mar 10, 2020
PhRMA Report Shows Nearly 400 Cell and Gene Therapies in Development to Target a Broad Range of Diseases
Mar 03, 2020
Innovative Forensic DNA Expands Investigative Genetic Genealogy Team
Feb 28, 2020
Ancestry® Announces Digitization of All 36 Million Available US Draft Cards, Answering More Members’ Questions About Family History
Feb 25, 2020
Geneanet, the Leading Genealogy Website in Europe, Launches Its DNA Matching Service
Feb 24, 2020
Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)
Feb 20, 2020
LumaCyte Expands into Europe Tackling Expansive Vaccine and Cell and Gene Therapy Markets
Feb 06, 2020
The global gene therapy market was valued at $393.35 million in 2018, and is estimated to reach $6,205.85 million by 2026, registering a CAGR of 34.8% from 2019 to 2026
Feb 04, 2020
Columbus Children's Foundation receives commitment to accelerate production of curative treatments for children with ultra-rare genetic diseases